Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and α-tocopherol

Free Radical Biology and Medicine

Volumn 27, Issue 9-10, 1999, Pages 1087-1094

  Hahnel, Daniela ^a   Beyer, Klaus ^a   Engelmann, Bernd ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diacyl PC; Free radicals; Lyso PC; Plasmenylcholine; Plasmenylethanolamine; Triton X 100

Indexed keywords

ALPHA TOCOPHEROL; PLASMALOGEN; POLYUNSATURATED FATTY ACID;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID OXIDATION; MEMBRANE DAMAGE; MICELLE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

AMIDINES; FREE RADICAL SCAVENGERS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; OXIDANTS; PEROXIDES; PLASMALOGENS; VITAMIN E;

LETHRINIDAE;

EID: 0033230115     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00142-2     Document Type: Article

References (21)

1. [1] Steinbrecher, U. P.; Parthasarathy, S.; Leake, D. S.; Witztum, J. L.; Steinberg, D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81:3883-3887; 1984.
2. [2] Folcik, V. A.; Nivar-Aristy, R. A.; Krajewski, L. P.; Cathcart, M. K. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96:504-510; 1995.
3. [3] Wieland, E.; Parthasarathy, S.; Steinberg, D. Peroxidase-dependent metal-independent oxidation of low density lipoproteins in vitro: a model for in vivo oxidation? Proc. Natl. Acad. Sci. USA 90:5929-5933; 1993.
4. [4] Heinecke, J. W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141:1-15; 1998.
5. [5] Savenkova, M. I.; Mueller, D. M.; Heinecke, J. W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:20394-20400; 1994.
6. [6] Reiss, D.; Beyer, K.; Engelmann, B. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem. J. 323:807-814; 1997.
7. [7] Broekman, M. J.; Handin, R. J.; Derksen, A.; Cohen, P. Distribution of phospholipids, fatty acids, and platelet factor 3 activity among subcellular fractions of human platelets. Blood 47:963-971; 1976.
8. [8] Calzada, C.; Bruckdorfer, K. R.; Rice-Evans, C. A. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 128:97-105; 1997.
9. [9] Bligh, E. G.; Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:912-917; 1959.
10. [10] Bräutigam, C.; Engelmann, B.; Reiss, D.; Reinhardt, U.; Thiery, J.; Richter, W. O.; Brosche, T. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis. Atherosclerosis 119:77-88; 1996.
11. [11] Havel, R. J.; Eder, H. A.; Bragdon, J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345-1353; 1955.
12. [12] Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254; 1976.
13. +)-induced oxidation in relation to changes in lipoprotein composition. Biochem. J. 319:217-227; 1996.
14. [14] Goyal, J.; Wang, K.; Liu, M.; Subbaiah, P. V. Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation. J. Biol. Chem. 272:16231-16239; 1997.
15. [15] Zoeller, R. A.; Morand, O. H.; Raetz, C. R. H. A possible role for plasmalogens in protecting animal cells against photosensitized killing. J. Biol. Chem. 263:11590-11596; 1988.
16. [16] Engelmann, B.; Bräutigam, C.; Thiery, J. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins. Biochem. Biophys. Res. Commun. 204:1235-1242; 1994.
17. [17] Jürgens, G.; Fell, A.; Chen, Q.; Paltauf, F. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogen. Chem. Phys. Lipids 77:25-31; 1995.
18. [18] Zommara, M.; Tachibana N.; Mitsui, K.; Nakatani, N.; Sakono, M.; Ikeda, I.; Imaizumi, K. Inhibitory effect of ethanolamine plasmalogen on iron- and copper-dependent lipid peroxidation. Free Radic. Biol. Med. 18:599-602; 1995.
19. [19] Sindelar, P. J.; Guan, Z.; Dallner, G.; Ernster, L. The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic. Biol. Med. 26:318-24; 1999.
20. [20] Hahnel, D.; Huber, T.; Kurze, V.; Beyer, K.; Engelmann, B. Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids. Biochem. J. 340:377-383; 1999.
21. [21] Chow, S. C.; Sisfontes, L.; Bjorkhem, I.; Jondal, M. Suppression of growth in a leukemic T cell line by n-3 and n-6 polyunsaturated fatty acids. Lipids 24:700-704; 1989.